answer text |
<p>As any responsible government does, we manage our vaccine supply to meet our projected
needs and to offer the best protection to those who need it, when they need it. Delays
to Valneva’s contracted delivery schedule have meant that their ability to deliver
an effective vaccine in the timeframe contracted for was unachievable. As such the
vaccine no longer aligns with its planned use in our vaccination programme. Given
the maturity of the UK’s vaccination programme, and with over 80% of the UK population
now double vaccinated and now an alternative (in the absence of Valneva's product)
autumn/ winter vaccination campaign underway, the government has therefore taken a
decision to cancel the agreement with Valneva. Due to commercial sensitivities, we
cannot disclose the details of our commercial discussions with them.</p><p> </p><p>UK
Government officials are engaged in constructive discussions with Valneva now to seek
to reach a mutually beneficial resolution to the matters.</p>
|
|